Coherus Oncology Inc (CHRS)

Gross Profit Growth

72.26%

Quarterly · Period ending:

CHRS logo

CHRS Gross Profit Growth

Year-over-year change vs the same period a year earlier

Latest reported72.26%
CHRS Quarterly Gross Profit YoY % (-26.87% → 72.26%)
High-resolution chart · PNG

CHRS gross profit growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Coherus Oncology Inc Gross Profit Growth — Quarterly
Period endingGross Profit Growth
72.2574%
95.2564%
-61.5153%
-86.2411%
-83.5055%
348.7917%
191.5912%
19.5103%
4.5943%
-94.4159%
-77.6661%
310.844%
-30.7034%
-69.3329%
-49.157%
-83.3559%
-31.112%
-32.8085%
-37.955%
-41.442%
-43.4843%
-30.9188%
-14.9115%
-0.6519%
51.5537%
213.4947%
535.2511%
479.3555%
412.3496%
236.9986%
13.7957%
34.92%
16.62%
52.5217%
46.8246%
-143.3799%
38.2139%
-1.2464%
-42.3788%
260.9507%
-2.7916%
-72.7305%
-100.5154%
-2,397.9951%
-258.7249%
-196.4894%
-154.9937%
44.8058%
-75.3769%
-26.8712%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.